NOD样受体蛋白3炎症小体活化介导脓毒症肠损伤模型的炎症反应与细胞凋亡
该研究为体外细胞实验,用Caco-2细胞分为空白对照组及LPS 1、2、4 mg/L组,于6、12、24小时检测。结果显示LPS组IL-6、TNF-α、IL-1β、IL-18呈剂量和时间依赖性升高,凋亡率亦增加,LPS 4 mg/L组24小时最显著。RT-qPCR和Western blot显示NLRP3、caspase-1、ASC表达上调,SIRT1表达下调。结论提示脓毒症肠损伤中炎症反应和凋亡可能与NLRP3炎症小体活化及SIRT1下调相关。
要点
- LPS 4 mg/L组24小时IL-6、TNF-α、IL-1β、IL-18均显著高于空白对照组(均P<0.05)。
- LPS 4 mg/L组24小时凋亡率(14.83±3.73)% vs 空白组(5.87±1.17)%,P<0.05。
- LPS 4 mg/L组24小时NLRP3 mRNA升高(8.20±2.82 vs 1.00±0.36),SIRT1 mRNA降低(0.58±0.01 vs 1.03±0.06),均P<0.05。
- LPS 4 mg/L组24小时NLRP3、caspase-1、ASC蛋白表达上调,SIRT1蛋白表达下调(均P<0.05)。
- 体外实验提示NLRP3炎症小体活化与SIRT1下调可能参与脓毒症肠损伤的炎症和凋亡过程。
适用人群与场景
- 体外培养的人结直肠腺癌细胞(Caco-2),取对数生长期细胞用于实验。
- 原文未提及临床患者纳入或排除人群,也未提及急诊、ICU或院前场景。
诊断标准与关键阈值
- 原文未提及临床诊断标准或评分界值;实验分组为空白对照组(完全培养基正常培养)和LPS 1、2、4 mg/L组(含相应浓度LPS的完全培养基)。
- 检测时间点为干预后6、12、24小时。
处置流程与药物剂量
- 原文为体外细胞实验,未涉及临床处置流程或药物剂量推荐。
红旗征与不能漏的情况
- 原文未提及临床红旗征或需紧急处理的情况。
研究设计与关键结果
- 研究类型为体外细胞实验,样本量未提及,单中心未提及;人群为Caco-2细胞。
- 干预为LPS 1、2、4 mg/L,对照为空白对照组;主要终点为炎症因子、凋亡率及NLRP3/SIRT1表达。
- LPS组IL-6、TNF-α、IL-1β、IL-18呈剂量和时间依赖性升高,LPS 4 mg/L组24小时最显著(均P<0.05)。
- LPS 4 mg/L组24小时凋亡率(14.83±3.73)% vs 空白组(5.87±1.17)%,P<0.05。
- LPS 4 mg/L组24小时NLRP3 mRNA(2-ΔΔCt)8.20±2.82 vs 1.00±0.36,SIRT1 mRNA 0.58±0.01 vs 1.03±0.06,均P<0.05。
- LPS 4 mg/L组24小时NLRP3蛋白(NLRP3/β-actin)1.48±0.03 vs 0.90±0.12,caspase-1蛋白1.18±0.11 vs 0.72±0.09,ASC蛋白1.09±0.01 vs 0.82±0.03,SIRT1蛋白0.48±0.03 vs 0.76±0.05,均P<0.05。
- 关键次要终点和不良事件原文未提及。
证据类型、等级与局限
- 证据类型为体外细胞实验(基础研究),非RCT、队列或系统评价;原文未给出证据等级或推荐强度。
- 局限:体外Caco-2细胞模型,不能直接外推至临床患者;样本量未提及;单中心未提及;开放标签不适用;仅观察相关性,未进行机制阻断或过表达验证。
对床旁实践的改变
- 该体外实验提示NLRP3炎症小体活化及SIRT1下调可能与脓毒症肠损伤的炎症和凋亡相关,但不能据此改变急诊或ICU的临床处置。
- 适用人群不明确(原文未提及临床患者),不适用于直接指导临床用药或剂量决策。
- 常见陷阱:将体外LPS浓度(1、2、4 mg/L)误读为临床血药浓度或治疗阈值;将相关性结论误读为因果或治疗推荐。
指南或共识出处
- 原文未提及
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To investigate the expression of NOD-like receptor protein 3 (NLRP3) inflammasome in intestinal injury models with different severity of sepsis and the inflammatory response and apoptosis mediated by NLRP3 inflammasome.
METHODS: Human colorectal adenocarcinoma cells (Caco-2) were cultured in vitro. The logarithmic growth phase cells were divided into blank control group (normal culture in complete medium) and lipopolysaccharide (LPS) 1, 2 and 4 mg/L groups (complete medium containing 1, 2 and 4 mg/L LPS, respectively). The supernatant were collected at 6, 12 and 24 hours, and the levels of tumor necrosis factor-α (TNF-α), interleukins (IL-6, IL-1β, IL-18) were detected by enzyme linked immunosorbent assay (ELISA). The apoptotic level of cells was detected by flow cytometry. The cells were harvested, and the real-time fluorescence quantitative reverse transcription-polymerase chain reaction (RT-qPCR) was used to detect the mRNA expressions of NLRP3 and silent information regulator 1 (SIRT1). Western blotting was used to detect the protein expressions of NLRP3, SIRT1, caspase-1 and apoptosis-associated speck-like protein (ASC).
RESULTS: ELISA results showed that the levels of IL-6, TNF-α, IL-1β, and IL-18 in cell supernatant of LPS groups increased in a dose-dependent and time-dependent manner as compared with the blank control group during the same intervention period. The increase was most significant in LPS 4 mg/L group at 24 hours [IL-6 (ng/L): 3.55±0.06 vs. 0.67±0.09, TNF-α (ng/L): 15.37±0.19 vs. 5.04±0.14, IL-1β (ng/L): 2.26±0.10 vs. 0.56±0.09, IL-18 (ng/L): 433.92±22.55 vs. 93.55±21.13, all P < 0.05]. The results of the apoptotic test showed that, compared with the blank control group, the apoptotic rate of LPS groups increased in a dose-dependent and time-dependent manner, and the apoptotic rate of LPS 4 mg/L group increased most significantly at 24 hours [(14.83±3.73)% vs. (5.87±1.17)%, P < 0.05]. RT-qPCR results showed that the expression level of NLRP3 mRNA was increased, while the expression level of SIRT1 mRNA was decreased with the increase of LPS intervention dose and the prolonging of intervention time. At 24 hours, there were significant differences between LPS 4 mg/L group and blank control group [NLRP3 mRNA (2-ΔΔCt): 8.20±2.82 vs. 1.00±0.36, SIRT1 mRNA (2-ΔΔCt): 0.58±0.01 vs. 1.03±0.06, both P < 0.05]. Western blotting showed that compared with the blank control group, the protein expression levels of NLRP3, caspase-1 and ASC in LPS groups were significantly increased, while the protein expression levels of SIRT1 were significantly decreased. During each intervention period, with the increase of LPS dose, the expressions of NLRP3, caspase-1 and ASC protein increased gradually, while the expression of SIRT1 protein decreased gradually. At 24 hours, the difference between the LPS 4 mg/L group and the blank control group was significant [NLRP3 protein (NLRP3/β-actin): 1.48±0.03 vs. 0.90±0.12, caspase-1 protein (caspase-1/β-actin): 1.18±0.11 vs. 0.72±0.09, ASC protein (ASC/β-actin) : 1.09±0.01 vs. 0.82±0.03, SIRT1 protein (SIRT1/β-actin): 0.48±0.03 vs. 0.76±0.05, all P < 0.05].
CONCLUSIONS: In vitro, in the sepsis induced intestinal inflammation model, with the increase of LPS intervention dose and the prolongation of intervention time, intestinal inflammatory response and cell apoptosis showed an increasing trend, which may be related to the up-regulation of NLRP3 inflammasome and its downstream products ASC and caspase-1, and to the down-regulation of SIRT1 expression.
参考来源
- Gulifeire T, Yang C, Li X, et al. [Activation of NOD-like receptor protein 3 inflammasome mediates inflammatory response and apoptosis in septic intestinal injury model]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2021. PMID: 34412757. doi:10.3760/cma.j.cn121430-20210323-00725
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。